Autotransfusion Systems Market

Executive Summary

Autotransfusion Systems Market was valued at US $425.78 million in 2021 and is projected to grow at 6.44% CAGR over the forecast period to reach US $619.30 million by 2027. Autotransfusion Systems Market represented US $49.99 million opportunity over 2019-2021 and estimated to create US $193.53 million opportunity in 2027 over 2021.

Autotransfusion Systems from Consainsights analyses the Autotransfusion Systems Market in the Life Sciences industry over the forecast period to 2027.

Autotransfusion Systems research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Autotransfusion Systems segmentation includes Type, Application, Region and Geography.

Based on the Type, the Autotransfusion Systems analysis covers Autotransfusion Products, Autotransfusion Accessories.

In Type segment, Autotransfusion Products segment has highest cagr growth of 5.71%.

Based on the Application, the Autotransfusion Systems analysis covers Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, Other Procedures.

In Application segment, Cardiac Surgeries segment has highest cagr growth of 5.71%.

Based on the Region, the Autotransfusion Systems analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 5.71%.

Based on the region, the Autotransfusion Systems analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Atrium Medical Corporation (A Part of Getinge Group), Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Haemonetics Corporation, Livanova PLC, Medtronic PLC, Redax, SARSTEDT AG & Co. Kg, Teleflex Incorporated, Zimmer Biomet Holdings Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Autotransfusion Products segment has the highest revenue of US $237.88 million and is expected to grow at CAGR of 5.71% by 2027 Autotransfusion Products segment has highest cagr growth of 5.71%.

Autotransfusion Products

Autotransfusion Products segment was valued at US $209.95 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $346.01 million by 2027. Autotransfusion Products segment represented US $27.93 million opportunity over 2019-2021 and estimated to create US $108.13 million opportunity in 2027 over 2021.

Autotransfusion Accessories

Autotransfusion Accessories segment was valued at US $165.83 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $273.29 million by 2027. Autotransfusion Accessories segment represented US $22.06 million opportunity over 2019-2021 and estimated to create US $85.40 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiac Surgeries segment has the highest revenue of US $186.94 million and is expected to grow at CAGR of 5.71% by 2027 Cardiac Surgeries segment has highest cagr growth of 5.71%.

Cardiac Surgeries

Cardiac Surgeries segment was valued at US $164.99 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $271.91 million by 2027. Cardiac Surgeries segment represented US $21.95 million opportunity over 2019-2021 and estimated to create US $84.97 million opportunity in 2027 over 2021.

Orthopedic Surgeries

Orthopedic Surgeries segment was valued at US $121.86 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $200.83 million by 2027. Orthopedic Surgeries segment represented US $16.21 million opportunity over 2019-2021 and estimated to create US $62.76 million opportunity in 2027 over 2021.

Organ Transplantation

Organ Transplantation segment was valued at US $56.85 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $93.70 million by 2027. Organ Transplantation segment represented US $7.56 million opportunity over 2019-2021 and estimated to create US $29.28 million opportunity in 2027 over 2021.

Trauma Procedures

Trauma Procedures segment was valued at US $25.66 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $42.29 million by 2027. Trauma Procedures segment represented US $3.41 million opportunity over 2019-2021 and estimated to create US $13.22 million opportunity in 2027 over 2021.

Other Procedures

Other Procedures segment was valued at US $6.42 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $10.58 million by 2027. Other Procedures segment represented US $0.85 million opportunity over 2019-2021 and estimated to create US $3.31 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $218.53 million and is expected to grow at CAGR of 5.71% by 2027 North America segment has highest cagr growth of 5.71%.

North America

North America segment was valued at US $192.87 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $317.86 million by 2027. North America segment represented US $25.66 million opportunity over 2019-2021 and estimated to create US $99.33 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $109.28 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $180.10 million by 2027. Europe segment represented US $14.54 million opportunity over 2019-2021 and estimated to create US $56.28 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $69.45 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $114.45 million by 2027. Asia Pacific segment represented US $9.24 million opportunity over 2019-2021 and estimated to create US $35.76 million opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $4.18 million in 2019 and is projected to grow at 5.71% CAGR over the forecast period to reach US $6.89 million by 2027. Rest of the World segment represented US $0.56 million opportunity over 2019-2021 and estimated to create US $2.15 million opportunity in 2027 over 2021.